High prevalence of pre-treatment HIV drug resistance in Papua New Guinea: findings from the first nationally representative pre-treatment HIV drug resistance study

Abstract Background Determining the prevalence of pre-treatment HIV drug resistance (PDR) is important to assess the effectiveness of first-line therapies. To determine PDR prevalence in Papua New Guinea (PNG), we conducted a nationally representative survey. Methods We used a two-stage cluster samp...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Janet Gare, Ben Toto, Percy Pokeya, Linh-Vi Le, Nick Dala, Namarola Lote, Bangan John, Abel Yamba, Kevin Soli, Joshua DeVos, Heather Paulin, Nick Wagar, Du-Ping Zheng, Takeshi Nishijima, Peniel Boas, Angela Kelly-Hanku, Anup Gurung
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMC 2022-03-01
coleção:	BMC Infectious Diseases
Assuntos:	Human immunodeficiency virus Pre-treatment drug resistance Antiretroviral therapy Papua New Guinea
Acesso em linha:	https://doi.org/10.1186/s12879-022-07264-y
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!